✦ LIBER ✦

Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: Results of a multicenter placebo-controlled double-blind trial

✍ Scribed by Diehm, C.; Balzer, K.; Bisler, H.; Bulling, B.; Camci, M.; Creutzig, A.; Gruss, J.D.; Horsch, S.; Odemar, F.; Piehler, U.; Rogatti, W.; Scheffler, P.; Spengel, F.; Treese, N.; Turowski, A.; Waldhausen, P.; Weber, B.; Weiss, T.

Book ID: 122167873
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 716 KB
Volume: 25
Category: Article
ISSN: 1097-6809
DOI: 10.1016/S0741-5214(97)70265-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of outpatient induction with lo

Efficacy of outpatient induction with low-dose intravaginal prostaglandin E2: A randomized, double-blind, placebo-controlled trial

✍ John M O'Brien; Brian M Mercer; Nancy T Cleary; Baha M Sibai 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 493 KB

Prophylactic antibiotics in severe acute

Prophylactic antibiotics in severe acute pancreatitis. Results of a double-blind, placebo-controlled multicenter trial

✍ Rainer Isenmann; Michael Ruenzi; Martina Kron; Harald Goebell; Hans G. Beger 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

A double-blind, randomized, placebo-cont

A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation

✍ Keith S. Henley; Michael R. Lucey; Daniel P. Normolle; Robert M. Merion; Ian D. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 774 KB

A double-blind placebo-controlled trial of intravenous prostaglandin PGE, (40 pg/h) was conducted in adult orthotopic liver transplant recipients. Infusion was started intraoperatively and continued for up to 21 days. Patients were followed up for 180 days postoperatively. Among 172 patients eligibl

A double-blind, randomized, placebo-cont

A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation*1

✍ HENLEY, K 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 797 KB

Results from a phase II multicenter, dou

Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease

✍ Paul Michael Grossman; Farrell Mendelsohn; Timothy D. Henry; James B. Hermiller; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Désirée van der Heijde; Alan Kivitz; Michael H. Schiff; Joachim Sieper; Ben A. C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views